Elsevier

Human Immunology

Volume 66, Issue 2, February 2005, Pages 170-210
Human Immunology

HLA dictionary 2004: Summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens

https://doi.org/10.1016/j.humimm.2004.09.017Get rights and content

Abstract

This report presents serologic equivalents of human leukocyte antigen (HLA)-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, and -DQB1 alleles. The dictionary is an update of the one published in 2001. The data summarize equivalents obtained by the World Health Organization (WHO) Nomenclature Committee for Factors of the HLA System, the International Cell Exchange (UCLA), the National Marrow Donor Program, recent publications, and individual laboratories. This latest update of the dictionary is enhanced by the inclusion of results from studies performed during the 13th International Histocompatibility Workshop and from neural network analyses. A summary of the data as recommended serologic equivalents is presented as expert assigned types. The tables include remarks for alleles, which are or may be expressed as antigens with serologic reaction patterns that differ from the well-established HLA specificities. The equivalents provided will be useful in guiding searches for unrelated hematopoietic stem cell donors in which patients and/or potential donors are typed by either serology or DNA-based methods. The serological-DNA equivalent dictionary will also aid in typing and matching procedures for organ transplant programs whose waiting lists of potential donors and recipients are comprised of mixtures of serologic and DNA-based typings. The tables with HLA equivalents and a questionnaire for submission of serologic reaction patterns for poorly identified allelic products will be made available through the World Marrow Donor Association Web page (http://www.worldmarrow.org).

Introduction

Several years ago, the World Marrow Donor Association initiated a study aimed at identifying the serological types associated with each human leukocyte antigen (HLA)-A, -B, -DRB allelic product. This work resulted in a “serology to DNA equivalents dictionary” first published in 1997 with updates in 1999 and 2001 [1, 2, 3]. The dictionary is a resource to aid searches for unrelated hematopoietic stem cell donors in adult volunteer and umbilical cord blood banks. Although most patients in need of hematopoietic stem cell transplantation are HLA typed by DNA-based methods at medium or high resolution, substantial parts of the donor registries predominantly provide only serologically based HLA typings, at least for HLA class I. In this respect, the dictionary can help in the search for donors whose HLA phenotypes closely resemble that of the patient even though these typings are determined by different methods [4]. Once identified, molecular class I typing of patient and selected donor can be performed to confirm the match. Since the publication of the 2001 dictionary [3] based on the alleles listed in the 2000 World Health Organization (WHO) Nomenclature report [5], a large number of additional alleles have received official allele designations [6]. The International Cell Exchange (UCLA), with its primary emphasis on recruitment of cells with new or rare alleles, contributed updated equivalent information for a number of specificities. Moreover, a reanalysis of the HLA typings in the National Marrow Donor Program (NMDP) volunteer donor database provided more reliable serologic equivalents for the DNA typed samples. Serologic equivalents have also been studied as a project of the 13th International Histocompatibility Workshop. For this project, a large number of cell samples with rare and newly identified HLA-A, -B, and -C alleles were collected worldwide and tested with well-defined sets of serologic reagents. A summary of those results has been included in this dictionary [7]. A new development is the serologic predictions by use of neural network (NN) analysis [8]. A summary of these predictions, updated to include newly defined alleles, has been implemented in this report. The serologic equivalents that are presented in the regular updates of the WHO nomenclature report form a matter of debate. For that reason, we now include a serologic equivalent termed expert assigned type, which summarizes our view on the most probable serologic equivalent for the alleles, which may differ from the WHO HLA assigned type. For completeness, all known alleles (four digits only) as included in the IMGT/HLA database [9] as of October 2003 have been included in TABLE 1, TABLE 2, TABLE 3, TABLE 4, TABLE 5, TABLE 6.

Although serological typing of HLA-C and -DQ antigens is notoriously difficult, often incomplete, and unreliable, the information, when available for a donor, may help in the selection procedure. For that reason, we have included HLA-C and -DQB1 serologic equivalents. Although HLA-DQ molecules are heterodimers combining polymorphic α- and β-chains, the DQ serologic patterns correlate strongly with DQB1, but not with DQA1 polymorphisms. For that reason, Table 6 gives equivalents between DQB1 alleles and DQ antigens.

Section snippets

WHO nomenclature: allele and serologic assignments

This update includes all presently identified alleles as included in the most recent nomenclature report [6] extended with the IMGT/HLA database update from October 2003. Alleles are presented with their four-digit number designation because silent substitutions (represented by the fifth and sixth digits) do not influence the antigenic expression. Nonexpressed (N-(ull))-alleles are included for completeness. This disregards the fact that some null alleles are actually rare subtypes of

International cell exchange, UCLA

The International Cell Exchange (UCLA) provided serologic equivalents for 43 HLA-A, 108 HLA-B, 33 HLA-C, 82 HLA-DRB1, 6 HLA-DRB3, 3 HLA-DRB4, 4 HLA-DRB5, and 17 HLA-DQB1 alleles. The HLA class I analysis included 120 new samples, cells 1065–1184, from healthy individuals, characterized between February 2001 and November 2003. In addition, two cells typed outside the above cell range were included to provide information for the rare alleles, B*2709 and Cw*1509, in TABLE 2, TABLE 3, respectively.

National marrow donor program

Cells from unrelated donors from the United States were HLA typed by means of serological and molecular methods by NMDP-affiliated laboratories. The NMDP data set is based on the typing information from 58,407 individuals for HLA-A; 95,764 individuals for HLA-B; 6234 individuals for HLA-C; 68,188 individuals for HLA-DRB1; and 51,382 individuals for HLA-DQB1. TABLE 1, TABLE 2, TABLE 3, TABLE 4, TABLE 6 present the number of individuals carrying a certain allele, together with the most frequent

NN

An artificial NN was used to predict serologic assignments for alleles lacking this information [8] and to support serologic assignments from other sources. The NN was trained with the polymorphic amino acid residues from the sequences of HLA-A, -B, and -DRB1 allelic products with well-established reference serologic types. The WHO HLA Nomenclature Committee-assigned serologic specificities, including most broad and split specificities, were included in the training set. After training of five

Serology-allele phenotype component of the 13th International Histocompatibility Workshop

One of the goals of this 13th International Histocompatibility Workshop (IHWG) component was to determine the serological assignment of HLA-A and -B and -C alleles whose serological reactivity was unknown or lacked complete characterization [10]. Cell samples including these alleles were made available by a number of laboratories and were tested with a common set of well-characterized reagents including mainly monoclonal antibodies and supplementary alloantisera. Twelve international

Information obtained from other sources

The comments column in the tables indicates references to recent publications that included remarks on the serologic expression of newly described alleles. Expression of alleles tested in the HLA-Club Cell Exchange is indicated in the tables as well. Also, personal communications to and local observations in the Leiden laboratory are included, but it should be realized that such observations are often based on very few samples tested in only one laboratory.

Expert assigned type

It was considered that the use of the dictionary would greatly improve if as many serologic equivalents could be provided as possible. Therefore, we include now an expert assigned type for HLA-A, -B, -C, -DRB1, -DRB3/4/5, and -DQB1, in which all possible information is combined. This expert assigned type may in some cases differ from the WHO nomenclature assignment. In cases where multiple assignments are possible (hybrid molecules), more antigen assignments are provided (see, e.g., A*3108 and

Use of dictionary in a hematopoietic stem cell donor search

The dictionary can be used to develop unrelated donor search strategies. First, the number of individuals tested as carrying a particular allele by the NMDP laboratories provides a rough estimate of allele frequency. For example, 10,841 individuals carried B*0702 compared with the smaller number of individuals who carried other B*07 alleles (e.g., 44 individuals carried B*0704). This suggests that a potential donor typed as B*07 (or B7) is most likely to carry B*0702. It also suggests that it

Serologic specificities lacking official WHO nomenclature designations

As the tables illustrate, a number of alleles appear with several common serologic assignments, indicating that their serologic reaction patterns are not well characterized. For example, the molecule encoded by B*4416 exhibits both B47 and B44 reactivity. A description of some of these variant reaction patterns for HLA allelic products is provided in the comments columns of the tables.

The majority of typing laboratories cannot readily identify a number of officially named HLA specificities.

Future reports of the links between alleles and serologic assignments

With the use of the serologic reagents of the 13th IHWG, a computational analysis was developed to map the amino acid residues that determine the epitopes in the different HLA alleles [11]. Through this analysis, the serologic reactivity of each HLA class I allele is analyzed with the complete 13th IHWG serum set, and the most likely serotype can be predicted. The assignment of likely serotypes obtained by this approach is underway, and future dictionary versions will include these results that

Acknowledgments

The efforts from the participants of the UCLA International Cell Exchange are acknowledged. We thank the typing laboratories in the Netherlands, Belgium, and Luxembourg, which participated in the HLA-Club Cell Exchange, for submitting, typing, and commenting on the samples with new and rare HLA alleles. This work was supported in part by the J.A. Cohen Institute for Radiopathology and Radioprotection (IRS), by the Dutch National Reference Center for Histocompatibility, and by the U.S. Office of

References (59)

  • S.G.E. Marsh et al.

    Nomenclature for factors of the HLA system, 2002

    Hum Immunol

    (2002)
  • M. Gutierrez et al.

    Serological assignment of reported novel HLA-A and -B alleles

    Hum Immunol

    (2002)
  • L. Cantwell et al.

    Identification of two new Cw alleles—implication for epitope recognition (abstract)

    Hum Immunol

    (2002)
  • C.K. Hurley et al.

    The search for HLA-matched donorsa summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A,-B,-DR antigens

    Tissue Antigens

    (1997)
  • G.M.T. Schreuder et al.

    The HLA dictionary 1999a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens

    Tissue Antigens

    (1999)
  • G.M. Th. Schreuder et al.

    The HLA dictionary 2001a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens

    Tissue Antigens

    (2001)
  • C.K. Hurley et al.

    Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships

    Bone Marrow Transplant

    (2004)
  • S.G.E. Marsh et al.

    Nomenclature for factors of the HLA system, 2000

    Tissue Antigens

    (2001)
  • G.M.T. Schreuder et al.

    The serologic specificity of HLA-A, -B and -C alleles defined with reagents of the 13th International Histocompatibility Workshop

  • M. Maiers et al.

    Use of a neural network to assign serologic specificities to HLA-A, -B and -DRB1 allelic products

    Tissue Antigens

    (2003)
  • J. Robinson et al.

    IMGT/HLA database—sequence database for the human major histocompatibility complex

    Tissue Antigens

    (2000)
  • M.A. Fernandez-Vina et al.

    Summary report of the serology-allele phenotype component of the 13th International Histocompatibility Workshop

  • M. Maiers et al.

    A computational approach to serologic epitope mapping

  • J. Street et al.

    Immunogenetics of two new HLA allelesA*0108 and B*4031

    Tissue Antigens

    (2003)
  • J. Street et al.

    Genetics, serology and sequences of six low frequency HLA-class I alleles (abstract)

    Eur J Immunogen

    (2001)
  • J. Street et al.

    Serological characterisation of the products of nine rare HLA class I alleles (abstract)

    Eur J Immunogen

    (2002)
  • K.L. Yang et al.

    Recognition of HLA-A*0248 in a Chinese donor

    Eur J Immunogen

    (2003)
  • C.E.M. Voorter et al.

    Identification of HLA-A*0249 and confirmation of A*2615

    Tissue Antigens

    (2002)
  • D. Czachurski et al.

    Characterization of a new HLA-A allele, A*0256, identified in a Caucasian individual

    Tissue Antigens

    (2002)
  • S. Day et al.

    Identification and characterization of a new HLA allele, A*0262 (abstract)

    Eur J Immunogen

    (2002)
  • J.D.H. Anholts et al.

    Five newly identified HLA allelesA*0310, A*2907, B*4435, Cw*0206, Cw*0506, and confirmation of A*3106, B*3924, Cw*0314, DRB1*0322 and DRB1*1433 alleles

    Tissue Antigens

    (2004)
  • C.-W. Pyo et al.

    Identification of HLA-A*11 variant (A*1107) in the Korean population

    Tissue Antigens

    (2001)
  • E. Palou et al.

    Identification and sequence characterization of a novel HLA-A11 serological variant (HLA-A*1108)

    Tissue Antigens

    (2001)
  • E. Garino et al.

    New HLA-A*11 allele, A*1112, identified by sequence-based typing

    Tissue Antigens

    (2002)
  • D. Takahashi et al.

    Identification of a novel allele HLA-A*1113 in a Japanese donor

    Tissue Antigens

    (2004)
  • G.-G. Wu et al.

    Identification of a new HLA allele, A*1114 in a Chinese family

    Tissue Antigens

    (2003)
  • J. Street et al.

    Observations on the HLA-A2403 specificity

    Tissue Antigens

    (2003)
  • C.E.M. Voorter et al.

    Molecular and serological identification of the HLA-A*3404 allele

    Tissue Antigens

    (2002)
  • B. Herbut et al.

    Identification of a novel HLA-B*07 allele—HLA-B*0726

    Tissue Antigens

    (2002)
  • Cited by (43)

    • Molecular HLA typing methods used in clinical laboratories

      2009, Molecular Diagnostics: Techniques and Applications for the Clinical Laboratory
    • Histocompatibility methods

      2009, Transplantation Reviews
      Citation Excerpt :

      Advantages of serologic typing include obtaining rapid results, which is of particular importance in deceased donor typing, and also the ability to discriminate “null” HLA alleles, which have detectable DNA sequences but no antigen expression on cell surfaces, and less immunologic relevance. However, finding high-quality sera with sufficient specificities to reflect the ever-increasing number of HLA alleles [19,20] is progressively prohibitive especially in light of increasing clinical interest in HLA-Cw, DP, and DP contributions to allograft outcomes. In addition, small differences in HLA molecules at the level of the amino acid sequence may not be identified using these methods despite potential immunologic consequences [21-26].

    • Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: Implications for dilated cardiomyopathy

      2009, International Journal of Cardiology
      Citation Excerpt :

      The investigation conformed with the principles outlined in the Declaration of Helsinki and was approved by the Committee for Scientific Research with Humans of the University Medical Center Rotterdam (MEC 215.732/2002/157). Typing for DQB1 and DRB1 human leukocyte antigens (HLA) was performed on PCR amplified DNA, using sequence specific oligonucleotides, [27], and results are shown as HLA-DQ and-DR antigens according to the latest HLA Dictionary [28]. Clinical condition was evaluated on the basis of the NYHA classification through the Modified Framingham Criteria for diagnosis of heart failure [29].

    • Association study of HLA-A gene and schizophrenia in Han Chinese from Taiwan

      2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    View all citing articles on Scopus
    View full text